Updated:
Gene Biotherapeutics, Inc.
Gene Biotherapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000772320, and its reported...
Overview
Gene Biotherapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000772320, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2022-03-30, it reported net income of USD -517,897; total assets of USD 566,982 for the fiscal period ended 2020-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Gene Biotherapeutics, Inc.
- Former names in filing history
- Taxus Cardium Pharmaceuticals Group Inc. (2014-03-18 to 2018-09-13); Cardium Therapeutics, Inc. (2005-05-31 to 2014-03-04); ARIES VENTURES INC (2000-06-19 to 2006-01-06); CASMYN CORP (1996-07-18 to 2000-05-09)
- Classification
- Company
- Industry (SIC)
- 2836 — Biological Products, (No Diagnostic Substances)
- Headquarters
- San Diego, CA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0000772320
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|
| FY2020USD | -$517,897 | $566,982 | $386,027 | -$1.1M | |
| FY2019USD | $866,675 | $35,435 | — | -$137,162 | |
| FY2016USD | -$2.9M | $1.1M | $930,397 | — | |
| FY2015USD | -$3.7M | $37,303 | $21,547 | — |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 10-K/A | Form 10-K/A | ||
| 10-K | Form 10-K | ||
| 10-Q | Form 10-Q | ||
| 10-Q | Form 10-Q | ||
| 10-Q | Form 10-Q | ||
| 8-K | Form 8-K | ||
| 8-K | Form 8-K | ||
| SC 13G | — | Form SC 13G | |
| 8-K | Form 8-K | ||
| 10-K | Form 10-K | ||
| SC 13D | — | Form SC 13D | |
| SC 13G | — | FORM SC 13G |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Gene Biotherapeutics, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.